MedTrace Logo

Evaluation of the Argos System to Estimate Cardiac Output

NCT07724262 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-07-24

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the reliability of the Argos system to track changes in cardiac output in critically ill patients. The main question it aims to answer is:

Does cardiac output changes induced by fluid administration or changes in norepinephrine dosage can be tracked by the Argos system, compared to transpulmonary thermodilution device.

Conditions

  • Shock

Interventions

DRUG

Fluid bolus

Giving a fluid bolus of 500mL of normal saline (NaCl 0.9%)

DRUG

Norepinephrine

brief, transient increase in norepinephrine to achieve a 15mmHg increase in mean arterial pressure and evaluates if tissue perfusion improves

Sponsors & Collaborators

  • Bicetre Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-12-31
Completion
2027-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07724262 on ClinicalTrials.gov